COVID-19 Illness in a Patient With Anti-Glomerular Basement Membrane Disease: A Clinical Dilemma.

Curēus
Vineeta VenkateswaranAnjan Trikha

Abstract

Anti-glomerular basement membrane (anti-GBM) disease is a rare autoimmune disease affecting the kidneys and lungs. COVID-19 infection in a patient with pre-existing anti-GBM disease presents a unique set of clinical challenges. The formulation of a judicious treatment plan balancing both disease processes is tricky, especially with regard to anticoagulation. We present the case of a young patient with anti-GBM disease who acquired COVID-19 infection and eventually succumbed to his illness.

References

May 19, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Stephen P McAdoo, Charles D Pusey
Jul 1, 2020·Kidney International·Maria PrendeckiStephen P McAdoo
Jul 11, 2020·JAMA : the Journal of the American Medical Association·W Joost WiersingaHallie C Prescott
Jul 16, 2020·Journal of Intensive Care Medicine·Seena TabibiMichael B Streiff
Nov 4, 2020·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Neriman Sila KocYunus Erdem
Nov 14, 2020·Thrombosis and Haemostasis·Henny H BillettEran Bellin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.